nvidia-to-launch-new-line-of-graphics-cards-with-samsung-8nm-process-this-month

Nvidia To Launch New Line Of Graphics Cards With Samsung 8nm Process This Month

NVDA) is out with a new line of graphics cards that it claims are two times faster than the predecessors.” data-reactid=”19″ type=”text”>Nvidia Corporation (NASDAQ: NVDA) is out with a new line of graphics cards that it claims are two times faster than the predecessors.

statement, these second-generation Ampere RTX cards are designed using ray-tracing technology.” data-reactid=”20″ type=”text”>What Happened: The company said in a statement, these second-generation Ampere RTX cards are designed using ray-tracing technology.

Bloomberg. The first generation used Taiwan Semicon Conductor Mfg Co’s (NYSE: TSM) 7nm process.” data-reactid=”21″ type=”text”>The chips for the upcoming launch will be built by Samsung Electronics using its 8nm process as opposed to the first generation of Ampere cards, according to Bloomberg. The first generation used Taiwan Semicon Conductor Mfg Co’s (NYSE: TSM) 7nm process.

Nvidia said its GeForce RTX 30 series uses faster third generation Tensor Cores and new streaming multiprocessors to boost visuals and AI acceleration for gaming. They feature an HDMI 2.1 that supports 4k high refresh rate and 8k gaming.

The top-end model RTX 3090 is priced at $1,499 whereas the base model is $499, and are expected to release later this month.

Advanced Micro Devices Inc (NASDAQ: AMD) recently released Radeon RX 5300 graphics card – a graphic processing unit that supports AAA, esports, and Virtual Reality titles.” data-reactid=”29″ type=”text”>Nvidia’s competitor, Advanced Micro Devices Inc (NASDAQ: AMD) recently released Radeon RX 5300 graphics card – a graphic processing unit that supports AAA, esports, and Virtual Reality titles.

Photo courtesy: Nvidia Corp.” data-reactid=”31″ type=”text”>Photo courtesy: Nvidia Corp.

  • AstraZeneca Lung Cancer Drug Gets EU Approval
  • Apple Readies To Sell 75M 5G iPhone Units Later This Year: Bloomberg
  • AstraZeneca COVID-19 Vaccine Candidate Moves Into Late-Stage US Clinical Trials With 30,000 Participants
  • Post navigation

    Leave a Comment

    Your email address will not be published. Required fields are marked *

    Scroll to Top